Buy Alunbrig 90mg Online
As a trusted online pharmacy with worldwide discreet delivery, we provide access to this groundbreaking medication that has shown tremendous promise in the fight against specific types of cancer.
What is Alunbrig 90mg?
Alunbrig 90mg is an oral medication that contains brigatinib, a potent and selective tyrosine kinase inhibitor (TKI). It is specifically designed to target and inhibit certain abnormal proteins known as anaplastic lymphoma kinase (ALK). This medication is primarily used for the treatment of ALK-positive metastatic non-small cell lung cancer (NSCLC), empowering patients to combat the disease and potentially extend their life expectancy.
Key Benefits:
- Targeted Therapy: Alunbrig 90mg acts as a precision medicine, selectively targeting and inhibiting ALK proteins in cancer cells. This targeted approach helps to disrupt the growth and spread of cancer, providing an effective treatment option for ALK-positive NSCLC patients.
- Improved Disease Management: By inhibiting the abnormal ALK proteins, Alunbrig 90mg helps to control the progression of metastatic NSCLC, reducing tumor size and preventing its spread to other parts of the body. This medication plays a crucial role in managing the disease and improving the overall quality of life for patients.
- Enhanced Survival Rates: Clinical studies have shown that Alunbrig 90mg has the potential to significantly extend the overall survival rates of ALK-positive NSCLC patients. This breakthrough treatment option offers hope for individuals who are in need of effective cancer therapy.
Why Choose Equicurepharm for Alunbrig 90mg?
- Genuine Medication: At Equicurepharm, we prioritize the safety and well-being of our customers. We source Alunbrig 90mg from trusted manufacturers, ensuring that you receive genuine and high-quality medication.
- Discreet Worldwide Delivery: We understand the sensitive nature of cancer treatment and prioritize your privacy. With our discreet worldwide delivery, you can rest assured that your Alunbrig 90mg will be delivered promptly and discreetly to your doorstep.
- Expert Support: Our dedicated team of professionals is here to provide you with comprehensive support and guidance throughout your treatment journey. We are committed to ensuring that you have a positive experience and access to the information you need.
Note: Alunbrig 90mg should only be used under the supervision and guidance of a qualified healthcare professional. It is important to discuss the potential benefits and risks of this medication with your doctor before starting any treatment.
Fight back against cancer with Alunbrig 90mg from Equicurepharm. Take advantage of this advanced treatment option and empower yourself in the battle against ALK-positive metastatic NSCLC. Place your order today and let us be a part of your fight for a brighter, healthier future.
Alunbrig 90mg (brigatinib)30 Brand Name : Briganix
Composition : Brigatinib 90mg
Manufactured by : Beacon Pharmaceuticals
Form : Tablet
Packing : Pack of 30 Tablets
Alunbrig 90mg 98.4 Pharmacy advice for Briganix 90mg 30 Tablets
- Severe, life-threatening, and fatal pulmonary adverse reactions consistent with interstitial lung disease (ILD)/pneumonitis have occurred with brigatinib; monitor for new or worsening respiratory symptoms (eg, dyspnea, cough), particularly during the first week of initiating.
- Dose-related hypertension reported; control BP prior to treatment; monitor BP after 2 weeks and at least monthly thereafter.
- Bradycardia (HR <50 bpm) reported; monitor HR and BP; monitor more frequently if concomitant use of drugs known to cause bradycardia cannot be avoided.
- May cause visual disturbances; advise patients to report any visual symptoms.
- Increased CPK reported; advise patients to report any unexplained muscle pain, tenderness, or weakness; monitor CPK during treatment.
- Serum pancreatic enzyme elevation reported; monitor lipase and amylase during treatment.
- May cause new or worsening hyperglycemia; assess fasting serum glucose before initiating drug and periodically thereafter; initiate or optimize antihyperglycemic medications as needed.
- Severe, life-threatening, and fatal pulmonary adverse reactions consistent with interstitial lung disease (ILD)/pneumonitis have occurred with brigatinib; monitor for new or worsening respiratory symptoms (eg, dyspnea, cough), particularly during the first week of initiating.
- Dose-related hypertension reported; control BP prior to treatment; monitor BP after 2 weeks and at least monthly thereafter.
- Bradycardia (HR <50 bpm) reported; monitor HR and BP; monitor more frequently if concomitant use of drugs known to cause bradycardia cannot be avoided.
- May cause visual disturbances; advise patients to report any visual symptoms.
- Increased CPK reported; advise patients to report any unexplained muscle pain, tenderness, or weakness; monitor CPK during treatment.
- Serum pancreatic enzyme elevation reported; monitor lipase and amylase during treatment.
- May cause new or worsening hyperglycemia; assess fasting serum glucose before initiating drug and periodically thereafter; initiate or optimize antihyperglycemic medications as needed.
Alunbrig 90mg
Be the first to review “Alunbrig 90mg”
Related products
Human Growth Hormone (HGH)
Human Growth Hormone (HGH)
Human Growth Hormone (HGH)
Human Growth Hormone (HGH)
Human Growth Hormone (HGH)
Human Growth Hormone (HGH)
Human Growth Hormone (HGH)
Reviews
There are no reviews yet.